Seroprevalence of SARS-CoV2 in IBD patients treated with biological therapy

BACKGROUND AND AIMS: A similar course of COVID-19 in patients with inflammatory bowel diseases (IBD) and in the general population has been reported. However, disease prevalence in IBD patients is presently unknown. In this prospective observational study we aimed at determining SARS-CoV2 infection...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Crohns Colitis
Prif Awduron: Berte', Roberto, Mazza, Stefano, Stefanucci, Marta Rachele, Noviello, Daniele, Costa, Stefania, Ciafardini, Clorinda, Mileti, Erika, Mapelli, Marina, Pasqualato, Sebastiano, Pinto, Sergio, Favale, Agnese, Vecchi, Maurizio, Neurath, Markus F, Atreya, Raja, Fantini, Massimo Claudio, Facciotti, Federica, Caprioli, Flavio
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2020
Pynciau:
Short Report
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7717179/
https://ncbi.nlm.nih.gov/pubmed/33211810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjaa237
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg